Distinct Effects Of Phosphodiesterase-5 And Fibroblast Growth Factor Receptor-1 Inhibitors In Monocrotaline-Induced Pulmonary Arterial Hypertension

被引：0
|
作者：
Felix, N. S. [1 ]
Mendonca, L. [1 ]
Da Silva, J. S. [1 ]
Braga, C. L. [1 ]
Samary, C. S. [1 ]
Cruz, F. F. [1 ]
Rocha, N. N. [1 ]
Zapata-Sudo, G. [1 ]
Rocco, P. R. M. [1 ]
Silva, P. L. [1 ]
机构：
[1] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3900
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison Between Phosphodiesterase-5 And Fibroblast Growth Factor Receptor-1 Inhibitors In Monocrotaline-Induced Pulmonary Arterial Hypertension
    Felix, N. S.
    Mendonca, L.
    Silva, J.
    Samary, C. D. S.
    Cruz, F. F.
    Rocha, N.
    Sudo, G.
    Rocco, P. R. M.
    Silva, P. L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [2] Improvement of exercise capacity in monocrotaline-induced pulmonary hypertension by the phosphodiesterase-5 inhibitor Vardenafil
    Schroll, Stephan
    Sebah, Daniela
    Wagner, Michael
    Popara, Viktoria
    Pfeifer, Michael
    Blumberg, Friedrich
    [J]. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2013, 186 (01) : 61 - 64
  • [3] Phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension
    Beltran-Gamez, Miguel E.
    Sandoval-Zarate, Julio
    Pulido, Tomas
    [J]. ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2015, 85 (03): : 215 - 224
  • [4] Treatment of pulmonary arterial hypertension with phosphodiesterase-5 inhibitors
    Ghofrani, H. A.
    Grimminger, F.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (49) : S311 - S314
  • [5] Efficacy of novel phosphodiesterase inhibitors in rats with monocrotaline-induced pulmonary hypertension
    Bruse, Kristy D.
    Pahl, Andreas
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2012, 66 (02) : 194 - 194
  • [6] Predictors of response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension
    Roberto Garcia, Agustin
    Blanco, Isabel
    Borras, Roger
    Lopez-Meseguer, Manuel
    Antonio Domingo-Morera, Juan
    Martin-Ontiyuelo, Clara
    Tura, Olga
    Otero-Gonzalez, Isabel
    Escribano-Subias, Pilar
    Albert Barbera, Joan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [7] Oral Therapies for Pulmonary Arterial Hypertension Endothelin Receptor Antagonists and Phosphodiesterase-5 Inhibitors
    Channick, Richard
    Preston, Iona
    Klinger, James R.
    [J]. CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 811 - +
  • [8] Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats
    Hongo, M
    Mawatari, E
    Tsutsui, H
    Yazaki, Y
    Kinoshita, O
    Ikeda, U
    [J]. JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S307 - S307
  • [9] Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats
    Hongo, M
    Mawatari, E
    Sakai, A
    Ruan, Z
    Koizumi, T
    Terasawa, F
    Yazaki, Y
    Kinoshita, O
    Ikeda, U
    Shibamoto, T
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (04) : 452 - 458
  • [10] Growth factor expression and effects of amrinone in monocrotaline-induced pulmonary hypertension in rats
    Burch, GH
    Jensen, LR
    Pappas, J
    Hammond, EH
    Banner, W
    Shaddy, RE
    [J]. BIOCHEMICAL AND MOLECULAR MEDICINE, 1996, 58 (02) : 204 - 210
12345